We are live on ! Find out more

13 hedge funds and large institutions have $9.96M invested in BioVie in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more capital invested

Capital invested by funds: $4.85M → $9.96M (+$5.11M)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

30% more funds holding

Funds holding: 1013 (+3)

0.05% more ownership

Funds ownership: 0.01%0.06% (+0.05%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
KC
1
Kepos Capital
New York
$4.18M +$6.7M +6,250 New
SM
2
Sabby Management
Florida
$3.38M +$5.41M +5,049 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.1M +$715K +667 +68%
S
4
swisspartners
Liechtenstein
$542K +$268K +250 +45%
Renaissance Technologies
5
Renaissance Technologies
New York
$355K +$270K +252 +90%
SC
6
Shay Capital
New York
$153K +$245K +229 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$127K -$41.8K -39 -17%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$71K +$114K +106 New
BlackRock
9
BlackRock
New York
$42K -$1.07K -1 -2%
Bank of America
10
Bank of America
North Carolina
$7K +$11.8K +11 New
Osaic Holdings
11
Osaic Holdings
Arizona
$4K
UBS Group
12
UBS Group
Switzerland
$1K -$19.3K -18 -95%
Morgan Stanley
13
Morgan Stanley
New York
$1K +$1.07K +1 New
Ameriprise
14
Ameriprise
Minnesota
-$1.23M -723 Closed
Northwestern Mutual Wealth Management
15
Northwestern Mutual Wealth Management
Wisconsin
-$7K -4 Closed
ASN
16
Advisory Services Network
Georgia
-$6K -3 Closed

BIVI Hedge Fund Activity: Q3 2021 in Review

13 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q3 2021, worth a combined $9.96M — up 105% from $4.85M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIVI positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Kepos Capital, opening a new position worth an estimated $6.7M. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.

  • 13 institutional investors held BioVie (BIVI) as of Q3 2021, up from 10 in Q2 2021.
  • Funds reported $9.96M of BioVie stock for Q3 2021, up 105% quarter-over-quarter.
  • 6 funds opened new BioVie positions in Q3 2021 and 3 closed out, a net change of +3 holders.
  • The largest BioVie buyer in Q3 2021 was Kepos Capital, an estimated $6.7M added.
  • The largest BioVie seller in Q3 2021 was Ameriprise, an estimated $1.23M sold.

Based on aggregated 13F filings for Q3 2021.